Sumon Mazumdar
Education
Ph.D., economics, Southern Methodist University; B.Sc., economics, St. Xavier’s College, Calcutta University
Summary of Experience
Dr. Mazumdar is a financial economist with over 25 years of experience advising clients in a wide range of industries on complex litigation issues. He has testified in a mediation, an arbitration, and in depositions, and has submitted expert reports in US federal and state courts and in US Tax Court.
As an expert in securities litigation, Dr. Mazumdar has testified on class certification issues and led consulting teams in analyzing class certification issues, materiality, loss causation, and damages claims in numerous securities fraud class action cases. As a valuation expert, Dr. Mazumdar has submitted expert reports and led consulting teams in cases related to the valuation of debt securities, derivatives, the net asset values of mutual fund shares, the valuation of biotech assets, and equity interests in partnerships. As a capital markets expert, Dr. Mazumdar has led consulting teams in cases related to mutual fund trading, algorithmic trading, foreign exchange, options trading, and the fiduciary processes used to manage 401(k) plans. As a damages expert, Dr. Mazumdar has led consulting teams to assess damages in a variety of cases.
In addition to his work as an economic consultant, Dr. Mazumdar is a member of the finance faculty at the Haas School of Business, University of California, Berkeley, where he teaches undergraduate and graduate courses on corporate finance and valuation. He also serves on the editorial board of the Journal of Investment Management –a finance journal with five Nobel laureates in economics on its advisory board – and on several American Bar Association (ABA) Section of Litigation leadership committees. He has held tenured professorships at McGill University and York University in Canada, and has served as a research scholar at the US Federal Reserve Bank of San Francisco. Dr. Mazumdar has published widely on valuation, banking, risk management, and securities law issues, and has presented his research before the Securities and Exchange Commission (SEC), the International Monetary Fund (IMF), and at major universities and conferences. His research has been cited by major news outlets, and in a brief presented to the US Supreme Court.
-
Biotech Asset Valuation Methods: A Practitioner’s Guide
Journal of Investment Management, Vol. 21, No. 4 (2023), pp. 1–21
2023 -
Cryptocurrencies Demystified and the SEC’s Regulatory Stance
American Bar Association, Litigation News, Summer 2018
2018Kim S, Mazumdar S
-
March 6, 2024
-
March 25, 2024
-
February 23, 2024
-
January 5, 2023